The ORR in patients with R/R IDH2-mutated AML was 40.3%, CR in 19.3%, and CRi in 6.8% (PR = 6.2%, morphological leukemia-free state = 8.0%). The gene discussed is IDH2; the disease is acute myeloid leukemia.